1. Retinal Nerve Fiber Layer Thickness Changes in Age-Related Macular Degeneration Treated with Multiple Intravitreal Ranibizumab
- Author
-
Özgür Artunay, Alev Kockar, Rifat Rasier, Melda Yenerel, Erdal Yuzbasioglu, Esra Türkseven Kumral, and Elvan Alper Şengül
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,genetic structures ,Nerve fiber layer ,Spectral domain ,Macular Degeneration ,03 medical and health sciences ,chemistry.chemical_compound ,Nerve Fibers ,0302 clinical medicine ,Optical coherence tomography ,Ranibizumab ,Age related ,Ophthalmology ,medicine ,Humans ,Pharmacology (medical) ,Prospective Studies ,Aged ,Pharmacology ,medicine.diagnostic_test ,business.industry ,Age Factors ,Retinal ,Macular degeneration ,medicine.disease ,eye diseases ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,Intravitreal Injections ,030221 ophthalmology & optometry ,Female ,sense organs ,Intravitreal ranibizumab ,business - Abstract
The objective of this study was to investigate the effect of multiple intravitreal ranibizumab (IVR) injections on the retinal nerve fiber layer (RNFL) in neovascular age-related macular degeneration (nAMD).One hundred sixty-eight eyes of 168 patients with nAMD who received an IVR at least 3 times were included in this prospective interventional case series. The RNFL thickness data on 80 healthy eyes, used as the control group, were obtained. The patients were grouped as follows: 3-10 injections (group 1, 62 eyes, 37%), 10-20 injections (group 2, 62 eyes, 37%), and ≥20 injections (group 3, 44 eyes, 26%). The RNFL thickness was measured by spectral domain optical coherence tomography.The mean baseline measurement of the RNFL thickness was 97.4 ± 6.4 μm in the control group, 96.4 ± 5.6 μm in group 1, 93.8 ± 4.6 μm in group 2, and 93.2 ± 5.3 μm in group 3. At the last follow-up, it was 95.1 ± 2.4 μm in the control group, 93.4 ± 7.3 μm in group 1, 90.5 ± 3.6 μm in group 2, and 89.2 ± 4.9 μm in group 3 (all P values0.050). A statistically significant difference was not found between the mean total RNFL thickness of the eyes that received injections and that of the eyes in the healthy control group (P value0.050). A statistically significant difference was not found in all the treatment groups between the intraocular pressure level taken 1 day after the administration of the injections and that recorded preintervention (all P values0.050).Repeated IVR did not lead to a significant change in RNFL thickness in patients with nAMD.
- Published
- 2016